GB9501841D0
(en)
*
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
GB9515182D0
(en)
*
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
IT1309592B1
(it)
*
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
SI1158958T1
(sl)
*
|
1999-03-05 |
2007-10-31 |
Chiesi Farma Spa |
Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo
|
GB0009468D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
PE20011227A1
(es)
*
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
GB0012261D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel process
|
CN100551358C
(zh)
*
|
2000-06-27 |
2009-10-21 |
维克多瑞有限公司 |
用于药物组合物的颗粒的制备方法
|
GB0027357D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
DK1337240T4
(en)
|
2000-11-30 |
2015-01-05 |
Vectura Ltd |
A process for the preparation of particles for use in a pharmaceutical composition
|
ATE446085T1
(de)
*
|
2000-11-30 |
2009-11-15 |
Vectura Ltd |
Partikel zur verwendung in einer pharmazeutischen zusammensetzung
|
AU2002222118A1
(en)
†
|
2000-11-30 |
2002-06-11 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
WO2002056948A1
(en)
|
2001-01-17 |
2002-07-25 |
Vectura Limited |
An inhaler device
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
JP2005507881A
(ja)
|
2001-09-17 |
2005-03-24 |
グラクソ グループ リミテッド |
乾燥粉末医薬製剤
|
US7931533B2
(en)
|
2001-09-28 |
2011-04-26 |
Igt |
Game development architecture that decouples the game logic from the graphics logics
|
SE0200312D0
(sv)
|
2002-02-01 |
2002-02-01 |
Astrazeneca Ab |
Novel composition
|
US20050191357A1
(en)
*
|
2002-03-20 |
2005-09-01 |
Yoshiaki Kawashima |
Method of manufacturing chemical-containing composite particles
|
FI116657B
(fi)
*
|
2002-03-28 |
2006-01-31 |
Focus Inhalation Oy |
Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
US8273331B2
(en)
*
|
2002-08-21 |
2012-09-25 |
Norton Healthcare Ltd. |
Inhalation compositions
|
WO2004028545A1
(en)
*
|
2002-09-25 |
2004-04-08 |
Astrazeneca Ab |
A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
EP1452179A1
(de)
*
|
2003-02-27 |
2004-09-01 |
CHIESI FARMACEUTICI S.p.A. |
Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
|
US20060147389A1
(en)
*
|
2004-04-14 |
2006-07-06 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
CA2522158C
(en)
*
|
2003-04-14 |
2018-03-20 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
US7094545B2
(en)
*
|
2003-04-30 |
2006-08-22 |
Ferring Bv |
Pharmaceutical composition as solid dosage form and method for manufacturing thereof
|
EP1643973A1
(de)
*
|
2003-07-11 |
2006-04-12 |
Glaxo Group Limited |
Pharmazeutische zusammensetzungen enthaltend magnesiumstearat
|
JP2009514779A
(ja)
*
|
2003-07-11 |
2009-04-09 |
グラクソ グループ リミテッド |
医薬製剤
|
CN1826099B
(zh)
*
|
2003-07-25 |
2010-06-09 |
凡林有限公司 |
固体剂型药物组合物及其制造方法
|
ATE301990T1
(de)
*
|
2003-07-25 |
2005-09-15 |
Ferring Bv |
Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
|
GB0327723D0
(en)
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0321607D0
(en)
*
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
EP1663164A2
(de)
*
|
2003-09-15 |
2006-06-07 |
Vectura Limited |
Verfahren zur herstellung von pharmazeutischen zusammensetzungen
|
GB0324918D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
AU2004294889B2
(en)
*
|
2003-12-03 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Medical product containing tiotropium
|
SE0303571D0
(sv)
*
|
2003-12-03 |
2003-12-22 |
Microdrug Ag |
Medical product for moisture-sensitive medicaments
|
SE0303569L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
DPI för avlämning av fuktkänsliga medikament
|
SE0303269L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Medicinsk produkt
|
US7018653B2
(en)
|
2003-12-29 |
2006-03-28 |
Ferring B.V. |
Method for preparing solid dosage form of desmopressin
|
JO3102B1
(ar)
|
2004-03-17 |
2017-09-20 |
Chiesi Framaceutici S P A |
صيغ صيدلانية لوسائل استنشاق بها مسحوق جاف تشتمل على مكون فعال بقوة منخفضة الجرعة
|
AU2005237523A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Cydex Pharmaceuticals, Inc. |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
GB0409703D0
(en)
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0425758D0
(en)
*
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
GB0426301D0
(en)
*
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
JP5156397B2
(ja)
|
2005-02-10 |
2013-03-06 |
グラクソ グループ リミテッド |
予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤
|
CN101171023A
(zh)
*
|
2005-03-09 |
2008-04-30 |
小野药品工业株式会社 |
一种粒子以及含有该粒子的制剂
|
JP2008534611A
(ja)
*
|
2005-03-30 |
2008-08-28 |
シェーリング コーポレイション |
抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
GB0525254D0
(en)
|
2005-12-12 |
2006-01-18 |
Jagotec Ag |
Powder compositions for inhalation
|
GB0613161D0
(en)
*
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
EP1944018A1
(de)
*
|
2007-01-10 |
2008-07-16 |
CHIESI FARMACEUTICI S.p.A. |
Mikronisierte Partikel mit niedrigdosierten Wirkstoffen für Pulverzubereitungen zur Inhalation
|
EP2120875B1
(de)
*
|
2007-02-11 |
2018-07-11 |
Map Pharmaceuticals Inc. |
Verfahren zur therapeutischen verabreichung von dhe zur schnellen linderung von migräne bei gleichzeitiger minimierung von nebenwirkungsprofilen
|
BRPI0814772A2
(pt)
|
2007-07-21 |
2015-03-03 |
Albany Molecular Res Inc |
Indazóis substituídos por 5-piridinona
|
EP2222639A1
(de)
|
2007-11-21 |
2010-09-01 |
Decode Genetics EHF |
Biaryle als pde4-inhibitoren zur behandlung von lungen- und herz-kreislauf-erkrankungen
|
WO2009088054A1
(ja)
|
2008-01-11 |
2009-07-16 |
Astellas Pharma Inc. |
精巣の疼痛又は不快感行動及び頻尿併発モデル動物
|
EP2240481A1
(de)
|
2008-01-11 |
2010-10-20 |
Albany Molecular Research, Inc. |
(1-azinon)-substituierte pyridoindole als mch-antagonisten
|
EP2080508A1
(de)
|
2008-01-15 |
2009-07-22 |
CHIESI FARMACEUTICI S.p.A. |
Trockenpulverformulierung mit einem anticholinergischen Arzneimittel
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
EP2191821A1
(de)
*
|
2008-11-26 |
2010-06-02 |
CHIESI FARMACEUTICI S.p.A. |
Mikropartikel enthaltend ein Salz von 8-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone mit verbesserten Adhesionseigenschaften zur Trockenpulver-Inhalation
|
US8673931B2
(en)
|
2009-01-26 |
2014-03-18 |
Abraham Fisher |
Bicyclic heterocyclic spiro compounds
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
WO2010097188A1
(en)
*
|
2009-02-25 |
2010-09-02 |
Chiesi Farmaceutici S.P.A. |
Inhalation particles comprising a salt of carmoterol and a corticosteroid
|
EP3578169B1
(de)
|
2009-02-26 |
2024-06-26 |
Glaxo Group Limited |
Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
EP2421514A2
(de)
*
|
2009-04-24 |
2012-02-29 |
Schering Corporation |
Agglomeratformulierungen für trockenpulver-inhaliergerät
|
WO2011015289A1
(en)
|
2009-08-04 |
2011-02-10 |
Chiesi Farmaceutici S.P.A. |
8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate
|
GB0918249D0
(en)
|
2009-10-19 |
2009-12-02 |
Respivert Ltd |
Compounds
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
EP2360147A1
(de)
|
2010-02-22 |
2011-08-24 |
CHIESI FARMACEUTICI S.p.A. |
Verfahren zur Herstellung von kristallinen Partikeln von einem Salz von 8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-chinolinon (Carmoterol)
|
KR101730684B1
(ko)
|
2010-04-01 |
2017-04-26 |
키에시 파르마슈티시 엣스. 피. 에이. |
흡입용 건조 분말을 위한 담체 입자 제조 방법
|
RU2580312C2
(ru)
*
|
2010-04-21 |
2016-04-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Способ получения частиц с пониженным электростатическим зарядом
|
SG185383A1
(en)
|
2010-04-30 |
2012-12-28 |
Alexion Pharma Inc |
Anti-c5a antibodies and methods for using the antibodies
|
WO2011152804A2
(en)
|
2010-06-03 |
2011-12-08 |
Mahmut Bilgic |
Process for dry powder formulations
|
BR112012032330A2
(pt)
|
2010-06-22 |
2016-11-08 |
Chiesi Farma Spa |
formulação em pó seco inalável, uso de uma formulação em pó seco, inalador de pó seco e embalagem
|
KR101805958B1
(ko)
*
|
2010-08-03 |
2017-12-07 |
키에시 파르마슈티시 엣스. 피. 에이. |
포스포디에스테라제 억제제를 포함하는 건조 분말 제제
|
US20130177651A1
(en)
*
|
2010-09-03 |
2013-07-11 |
Pharmaterials Limited |
Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
|
AU2011308865B2
(en)
|
2010-09-29 |
2017-01-05 |
Pulmatrix, Inc. |
Monovalent metal cation dry powders for inhalation
|
WO2012041717A1
(en)
|
2010-09-30 |
2012-04-05 |
Chiesi Farmaceutici S.P.A. |
Use of magnesium stearate in dry powder formulations for inhalation
|
UY33337A
(es)
|
2010-10-18 |
2011-10-31 |
Respivert Ltd |
DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
|
US9808030B2
(en)
|
2011-02-11 |
2017-11-07 |
Grain Processing Corporation |
Salt composition
|
TR201205852A2
(tr)
*
|
2011-06-02 |
2012-12-21 |
Bi̇lgi̇ç Mahmut |
Geliştirilmiş yeni kuru toz formülasyonu.
|
TR201105367A2
(tr)
*
|
2011-06-02 |
2012-12-21 |
Bi̇lgi̇ç Mahmut |
Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
|
WO2013109208A1
(en)
*
|
2012-01-16 |
2013-07-25 |
Mahmut Bilgic |
Formulations comprising formoterol as active agent
|
WO2013109214A1
(en)
*
|
2012-01-16 |
2013-07-25 |
Mahmut Bilgic |
Process for the preparation of dry powder formulations
|
WO2013109211A1
(en)
*
|
2012-01-16 |
2013-07-25 |
Mahmut Bilgic |
Dry powder formulations comprising r-formoterol as active agent
|
CN105726548B
(zh)
*
|
2012-01-25 |
2019-05-14 |
奇斯药制品公司 |
用于吸入给药包含皮质类固醇和beta-肾上腺素能药物的干粉配制剂
|
EP2809780B1
(de)
|
2012-02-01 |
2018-05-02 |
Protalix Ltd. |
Inhalierbare flüssige formulierungen der dnase i
|
NZ629722A
(en)
|
2012-02-29 |
2017-03-31 |
Pulmatrix Operating Co Inc |
Inhalable dry powders
|
SG11201404522VA
(en)
|
2012-03-13 |
2014-10-30 |
Respivert Ltd |
Crystalline pi3 kinase inhibitors
|
KR20140147891A
(ko)
|
2012-04-13 |
2014-12-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
응집체 입자
|
US10105316B2
(en)
|
2012-07-05 |
2018-10-23 |
Arven llac Sanayi Ve Ticaret A.S. |
Inhalation compositions comprising muscarinic receptor antagonist
|
US10111957B2
(en)
*
|
2012-07-05 |
2018-10-30 |
Arven Ilac Snayi ve Ticaret A.S. |
Inhalation compositions comprising glucose anhydrous
|
CN109846862A
(zh)
|
2012-10-25 |
2019-06-07 |
通用医疗公司 |
治疗阿尔茨海默病及相关疾病的组合疗法
|
US11052202B2
(en)
|
2012-11-07 |
2021-07-06 |
Chiesi Farmaceutici S.P.A. |
Drug delivery device for the treatment of patients with respiratory diseases
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
SG11201505835QA
(en)
|
2013-01-28 |
2015-08-28 |
Incozen Therapeutics Pvt Ltd |
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
|
GB201305825D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
US20160051673A1
(en)
|
2013-03-29 |
2016-02-25 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5
|
EP3607941A1
(de)
|
2013-04-30 |
2020-02-12 |
Otitopic Inc. |
Trockenpulverformulierungen und verfahren zur verwendung
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
PL2821061T3
(pl)
*
|
2013-07-01 |
2018-05-30 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Nowe preparaty do inhalacji
|
SI3019153T1
(sl)
*
|
2013-07-11 |
2018-12-31 |
Chiesi Farmaceutici S.P.A. |
Formulacija suhega praška, obsegajoča antiholinergik, kortikosteroid in beta-adrenergik, za dajanje z inhalacijo
|
EP3052092A2
(de)
*
|
2013-10-02 |
2016-08-10 |
Vectura Limited |
Verfahren und vorrichtung
|
US9427376B2
(en)
|
2013-10-10 |
2016-08-30 |
Chiesi Farmaceutici S.P.A. |
Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
|
US10188757B2
(en)
|
2013-10-22 |
2019-01-29 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
US9554992B2
(en)
|
2014-06-09 |
2017-01-31 |
Chiesi Farmaceutici S.P.A. |
Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
EP2957552B1
(de)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterolformulierungen
|
WO2016005443A1
(en)
*
|
2014-07-09 |
2016-01-14 |
Arven Ilac Sanayi Ve Ticaret A.S. |
A process for the preparation of formulations for inhalation
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
WO2016067252A1
(en)
|
2014-10-31 |
2016-05-06 |
Glaxosmithkline Intellectual Property Development Limited |
Powder formulation
|
US10655408B2
(en)
*
|
2015-06-23 |
2020-05-19 |
Schlumberger Technology Corporation |
Mobile proppant recognition
|
US11224594B2
(en)
*
|
2015-09-16 |
2022-01-18 |
Philip Morris Products S.A. |
Nicotine formulations and methods of making and using the same
|
LT3377108T
(lt)
|
2015-11-16 |
2020-07-10 |
Chiesi Farmaceutici S.P.A. |
Inhaliacinių miltelių kompozicijos, apimančios anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, paruošimo būdas
|
DK3689379T3
(da)
*
|
2015-11-16 |
2021-09-06 |
Chiesi Farm Spa |
Fremgangsmåde til fremstilling af en tørpulverformulering omfattende et anticholinergikum, et corticosteroid og et beta-adrenergikum
|
MX2018007512A
(es)
*
|
2015-12-24 |
2018-09-17 |
Philip Morris Products Sa |
Capsula de particula de nicotina.
|
CA3033079A1
(en)
|
2016-08-31 |
2018-03-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
CA3059824A1
(en)
*
|
2017-05-11 |
2018-11-15 |
Chiesi Farmaceutici S.P.A. |
A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
|
KR102637303B1
(ko)
*
|
2017-05-11 |
2024-02-20 |
키에시 파르마슈티시 엣스. 피. 에이. |
항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제의 제조 방법
|
US10583085B2
(en)
*
|
2017-05-17 |
2020-03-10 |
Chiesi Farmaceutici S.P.A. |
Carrier particles for dry powder formulations for inhalation
|
EA202090247A1
(ru)
|
2017-07-14 |
2020-05-12 |
Цитомкс Терапьютикс, Инк. |
Антитела против cd166 и их применения
|
WO2019019040A1
(en)
*
|
2017-07-26 |
2019-01-31 |
Shenzhen Xpectvision Technology Co., Ltd. |
SYSTEM HAVING SPATIALLY EXPANDED X-RAY SOURCE FOR X-RAY IMAGING
|
DK3658184T3
(da)
|
2017-07-27 |
2023-11-27 |
Alexion Pharma Inc |
Højkoncentrerede anti-c5-antistofformuleringer
|
WO2019060604A1
(en)
|
2017-09-20 |
2019-03-28 |
Teva Branded Pharmaceutical Products R&D, Inc. |
INHALABLE MEDICINE
|
AU2017432640B2
(en)
*
|
2017-09-22 |
2023-11-30 |
Vectura Inc. |
Dry powder compositions with magnesium stearate
|
WO2019060797A1
(en)
|
2017-09-22 |
2019-03-28 |
Teva Branded Pharmaceutical Products R&D, Inc. |
PROCESS FOR PRODUCING POWDERS FOR INHALING
|
US10786456B2
(en)
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
WO2019067708A1
(en)
*
|
2017-09-27 |
2019-04-04 |
Teva Branded Pharmaceutical Products R&D, Inc. |
METHOD FOR DECREASING PARTICLE SIZE
|
WO2020010049A1
(en)
*
|
2018-07-02 |
2020-01-09 |
The General Hospital Corporation |
POWDERED FORMULATIONS OF CROMOLYN SODIUM AND α-LACTOSE
|
JP7439084B2
(ja)
|
2018-07-27 |
2024-02-27 |
シエシー ファルマセウティチィ ソシエタ ペル アチオニ |
吸入用乾燥粉末製剤のための新規担体粒子
|
JP2021536467A
(ja)
|
2018-09-06 |
2021-12-27 |
インノファーマスクリーン インコーポレイテッド |
喘息またはパーキンソン病の処置のための方法および組成物
|
EP3873574B1
(de)
|
2018-10-30 |
2023-12-06 |
Chiesi Farmaceutici S.p.A. |
Vorrichtung zur verabreichung von arzneimitteln an mechanisch beatmete patienten
|
EP3893899A2
(de)
|
2018-12-12 |
2021-10-20 |
Kite Pharma, Inc. |
Chimäre antigen-rezeptoren und car-t-zellen und verwendungsverfahren
|
MX2021013329A
(es)
|
2019-04-29 |
2022-03-17 |
Insmed Inc |
Composiciones de polvo seco de los profarmacos de treprostinil y métodos de uso de las mismas.
|
WO2021058454A1
(en)
|
2019-09-24 |
2021-04-01 |
Chiesi Farmaceutici S.P.A. |
Novel carrier particles for dry powder formulations for inhalation
|
WO2021217024A1
(en)
|
2020-04-24 |
2021-10-28 |
Millennium Pharmaceuticals, Inc. |
Anti-cd19 antibodies and uses thereof
|
WO2021237109A1
(en)
|
2020-05-22 |
2021-11-25 |
Trailhead Biosystems Inc. |
Combination therapy for treatment of viral infections
|
CN112451509B
(zh)
*
|
2020-12-19 |
2023-03-07 |
沈阳药科大学 |
一种川丁特罗吸入粉雾剂及其制备方法
|
EP4320149A1
(de)
|
2021-04-09 |
2024-02-14 |
Takeda Pharmaceutical Company Limited |
Gegen komplementfaktor d gerichtete antikörper und verwendungen davon
|
WO2022232035A1
(en)
|
2021-04-26 |
2022-11-03 |
Millennium Pharmaceuticals, Inc. |
Anti-adgre2 antibodies and uses thereof
|
CA3216770A1
(en)
|
2021-04-26 |
2022-11-03 |
Tomoki Yoshihara |
Anti-clec12a antibodies and uses thereof
|
IL311837A
(en)
|
2021-10-20 |
2024-05-01 |
Takeda Pharmaceuticals Co |
BCMA designated preparations and methods for their use
|
WO2023117967A1
(en)
|
2021-12-21 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Dry powder formulations filled in an inhaler with improved resistance to humidity
|
WO2023117985A1
(en)
|
2021-12-21 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Dry powder formulations filled in an inhaler with improved resistance to humidity
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
WO2024062007A1
(en)
|
2022-09-22 |
2024-03-28 |
Chiesi Farmaceutici S.P.A. |
Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor
|